search
Back to results

Third Eye Retroscope Randomized Clinical Evaluation (TERRACE)

Primary Purpose

Colorectal Neoplasms

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Third Eye Retroscope
Sponsored by
Avantis Medical Systems
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Colorectal Neoplasms focused on measuring Colorectal, Neoplasms, Adenomas, Polyps, Miss rates, Detection rates, Colonoscope, Third Eye Retroscope

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup;
  • The patient must understand and provide written consent for the procedure.

Exclusion Criteria:

  • Patients with a history of colonic resection;
  • Patients with inflammatory bowel disease;
  • Patients with a personal history of polyposis syndrome;
  • Patients with suspected chronic stricture potentially precluding complete colonoscopy;
  • Patients with diverticulitis or toxic megacolon;
  • Patients with a history of radiation therapy to abdomen or pelvis;
  • Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.

Sites / Locations

  • Johns Hopkins Hospital
  • Kansas City Veterans Administration Medical Center
  • Dartmouth-Hitchcock Medical Center
  • Bayside Endoscopy Center
  • Baylor University Medical Center
  • Cliniques Universitaires Saint-Luc
  • Istituto Clinico Humanitas
  • University Medical Center Utrecht
  • St. Mark's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Group A - COLO, then TER

Group B - TER, then COLO

Arm Description

Complete examination with standard colonoscope ("COLO") followed by complete examination with Third Eye Retroscope ("TER") used in conjunction with standard colonoscope

Complete examination with Third Eye Retroscope ("TER") used in conjunction with standard colonoscope, followed by complete examination with standard colonoscope ("COLO") alone

Outcomes

Primary Outcome Measures

Detection Rates for Adenomas and for Total Polyps
Numbers of polyps and adenomas detected in first and second procedures for each group

Secondary Outcome Measures

Times for Withdrawal Phase and for Complete Procedure
For all examinations with each method (SC or TEC), mean time for withdrawal phase and mean time for total procedure

Full Information

First Posted
January 6, 2010
Last Updated
June 26, 2017
Sponsor
Avantis Medical Systems
search

1. Study Identification

Unique Protocol Identification Number
NCT01044732
Brief Title
Third Eye Retroscope Randomized Clinical Evaluation
Acronym
TERRACE
Official Title
Third Eye Retroscope Randomized Clinical Evaluation (The "TERRACE" Study)
Study Type
Interventional

2. Study Status

Record Verification Date
June 2017
Overall Recruitment Status
Completed
Study Start Date
March 2009 (undefined)
Primary Completion Date
February 2010 (Actual)
Study Completion Date
February 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Avantis Medical Systems

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The Third Eye® Retroscope® is a device that can be inserted through the instrument channel of a standard colonoscope to provide an additional, retrograde (or backward) view that reveals areas behind folds and flexures in the colon, and might detect additional polyps that cannot be seen with the colonoscope alone. Patients who participate as subjects in the study will undergo two complete colonoscopy procedures, a standard colonoscopy and a colonoscopy in which a Third Eye Retroscope is used along with the same colonoscope. Half of the patients will have the standard colonoscopy first followed by the Third Eye colonoscopy, and the other half will have the Third Eye procedure first. Results from the two groups will be analyzed and compared to determine the effectiveness of the Third Eye Retroscope for detecting additional adenomas and other polyps compared with the standard colonoscope alone.
Detailed Description
Colonoscopy is generally agreed to be the best method for detecting and removing pre-cancerous polyps, but some lesions can be missed, especially if they are located behind folds in the lining of the colon or behind flexures (sharp bends) in the colon. The Third Eye® Retroscope® is a device that can be inserted through the instrument channel of a standard colonoscope to provide an additional, retrograde (or backward) view that reveals areas behind folds and flexures in the colon. Previous studies have shown the device to be effective for detecting additional polyps that could not have been seen with the colonoscope alone. The purpose of this research is to compare the additional diagnostic yield obtained by using the Third Eye® Retroscope® vs. the diagnostic yield for the standard colonoscope alone in the context of a randomized, controlled study design. Patients who are scheduled for colonoscopy will be recruited to the study and randomized to one of two groups. Each patient will undergo two "back-to-back" procedures. Patients in Group A (study group) will undergo a standard colonoscopy followed immediately by a Third Eye colonoscopy. Patients in Group B (control group) will undergo a Third Eye colonoscopy followed immediately by a standard colonoscopy. Results from the two groups will be analyzed and compared to determine the effectiveness of the Third Eye Retroscope for detecting additional adenomas and other polyps compared with the standard colonoscope alone.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Neoplasms
Keywords
Colorectal, Neoplasms, Adenomas, Polyps, Miss rates, Detection rates, Colonoscope, Third Eye Retroscope

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Masking Description
Open Label
Allocation
Randomized
Enrollment
448 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group A - COLO, then TER
Arm Type
Experimental
Arm Description
Complete examination with standard colonoscope ("COLO") followed by complete examination with Third Eye Retroscope ("TER") used in conjunction with standard colonoscope
Arm Title
Group B - TER, then COLO
Arm Type
Active Comparator
Arm Description
Complete examination with Third Eye Retroscope ("TER") used in conjunction with standard colonoscope, followed by complete examination with standard colonoscope ("COLO") alone
Intervention Type
Device
Intervention Name(s)
Third Eye Retroscope
Intervention Description
Device used with colonoscope to provide second, retrograde view of the colon
Primary Outcome Measure Information:
Title
Detection Rates for Adenomas and for Total Polyps
Description
Numbers of polyps and adenomas detected in first and second procedures for each group
Time Frame
Acute - subjects were followed for the duration of the procedures, an average of 40 minutes.
Secondary Outcome Measure Information:
Title
Times for Withdrawal Phase and for Complete Procedure
Description
For all examinations with each method (SC or TEC), mean time for withdrawal phase and mean time for total procedure
Time Frame
Acute - subjects were followed for the duration of the procedures, an average of 40 minutes.

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup; The patient must understand and provide written consent for the procedure. Exclusion Criteria: Patients with a history of colonic resection; Patients with inflammatory bowel disease; Patients with a personal history of polyposis syndrome; Patients with suspected chronic stricture potentially precluding complete colonoscopy; Patients with diverticulitis or toxic megacolon; Patients with a history of radiation therapy to abdomen or pelvis; Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter D. Siersema, MD, PhD
Organizational Affiliation
UMC Utrecht
Official's Role
Principal Investigator
Facility Information:
Facility Name
Johns Hopkins Hospital
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21231
Country
United States
Facility Name
Kansas City Veterans Administration Medical Center
City
Kansas City
State/Province
Missouri
ZIP/Postal Code
64128
Country
United States
Facility Name
Dartmouth-Hitchcock Medical Center
City
Lebanon
State/Province
New Hampshire
ZIP/Postal Code
03756
Country
United States
Facility Name
Bayside Endoscopy Center
City
Providence
State/Province
Rhode Island
ZIP/Postal Code
02905
Country
United States
Facility Name
Baylor University Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75246
Country
United States
Facility Name
Cliniques Universitaires Saint-Luc
City
Brussels
ZIP/Postal Code
B-1200
Country
Belgium
Facility Name
Istituto Clinico Humanitas
City
Milan
ZIP/Postal Code
20089 Rozzano
Country
Italy
Facility Name
University Medical Center Utrecht
City
Utrecht
ZIP/Postal Code
3584 CX
Country
Netherlands
Facility Name
St. Mark's Hospital
City
London
ZIP/Postal Code
HA1 3UJ
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Aggregated, de-identified data to be published in peer-reviewed medical journal
Citations:
PubMed Identifier
21067735
Citation
Leufkens AM, DeMarco DC, Rastogi A, Akerman PA, Azzouzi K, Rothstein RI, Vleggaar FP, Repici A, Rando G, Okolo PI, Dewit O, Ignjatovic A, Odstrcil E, East J, Deprez PH, Saunders BP, Kalloo AN, Creel B, Singh V, Lennon AM, Siersema PD; Third Eye Retroscope Randomized Clinical Evaluation [TERRACE] Study Group. Effect of a retrograde-viewing device on adenoma detection rate during colonoscopy: the TERRACE study. Gastrointest Endosc. 2011 Mar;73(3):480-9. doi: 10.1016/j.gie.2010.09.004. Epub 2010 Nov 10.
Results Reference
result
PubMed Identifier
22807609
Citation
Siersema PD, Rastogi A, Leufkens AM, Akerman PA, Azzouzi K, Rothstein RI, Vleggaar FP, Repici A, Rando G, Okolo PI, Dewit O, Ignjatovic A, Odstrcil E, East J, Deprez PH, Saunders BP, Kalloo AN, Creel B, Singh V, Lennon AM, DeMarco DC. Retrograde-viewing device improves adenoma detection rate in colonoscopies for surveillance and diagnostic workup. World J Gastroenterol. 2012 Jul 14;18(26):3400-8. doi: 10.3748/wjg.v18.i26.3400.
Results Reference
result

Learn more about this trial

Third Eye Retroscope Randomized Clinical Evaluation

We'll reach out to this number within 24 hrs